Rapid Micro Biosystems, Inc.
RPIDNasdaqCIK 1380106TechnologyFiscal year ends Dec 31
Reports and events: 79 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-0507:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-23-000072 |
| 2023-03-2117:09 ET | DEF 14A | Proxy statementPeriod 2023-05-04 | 0001380106-23-000041 |
| 2023-03-1017:30 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001380106-23-000016 |
| 2023-03-0307:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-23-000011 |
| 2023-01-1109:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-23-000004 |
| 2022-12-0108:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001380106-22-000054 |
| 2022-11-1016:44 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001380106-22-000048 |
| 2022-11-1007:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-22-000044 |
| 2022-08-2910:35 ET | SC 13D/A | Ownership report, active investor, amended | 0001011438-22-000255 |
| 2022-08-1209:21 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013413 |
| 2022-08-1207:30 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-013401 |
| 2022-06-3008:30 ET | SC 13D | Ownership report, active investor | 0001011438-22-000232 |
| 2022-05-2617:06 ET | 8-K | 5.07 Shareholder vote results | 0001380106-22-000034 |
| 2022-05-1017:25 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001380106-22-000029 |
| 2022-05-1007:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-22-000026 |
| 2022-04-0816:29 ET | DEF 14A | Proxy statementPeriod 2022-05-23 | 0001140361-22-013797 |
| 2022-03-2917:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001380106-22-000015 |
| 2022-03-2417:27 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001380106-22-000010 |
| 2022-03-0406:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-22-000007 |
| 2022-01-1006:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-22-000003 |
| 2021-12-2317:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001380106-21-000019 |
| 2021-11-1509:12 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001380106-21-000015 |
| 2021-11-1209:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-21-000008 |
| 2021-09-2316:45 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001558370-21-012702 |
| 2021-08-2708:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-012104 |
| 2021-08-2616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-109803 |
| 2021-07-2117:57 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-21-094046 |
| 2021-07-1206:05 ET | S-1/A | Registration statement, amended | 0001104659-21-090822 |
| 2021-06-2516:49 ET | S-1 | Registration statement | 0001104659-21-085783 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.